Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05926830
Other study ID # HIFU-VN-FDA-VEINRESET 01
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 12, 2023
Est. completion date September 2025

Study information

Verified date June 2024
Source Theraclion
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a multi-center series assessment with a planned accrual of 70 patients with diagnosed symptomatic primary GSV insufficiency. Patients will be consented at a Pre-Study Visit and evaluated for eligibility and for baseline characteristics of the disease. Patients will receive treatment with Sonovein for the targeted segments of GSV. At follow-up visits at 7 days (1 to 10 days), 3 months (+/- 20 days), 6 months (+/- 25 days), and 12 months (+/- 30 days) changes in veins and flow characteristics will be evaluated by ultrasound, and patient well-being, including pain which will be evaluated by patient-reported VAS evaluations. Continued follow-up for a total of 12 months will be completed prior to subject study exit. Adverse events (AE) will be assessed at every study visit following HIFU treatment.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 70
Est. completion date September 2025
Est. primary completion date July 2025
Accepts healthy volunteers No
Gender All
Age group 22 Years and older
Eligibility Inclusion Criteria: - Candidate for venous procedure with primary GSV insufficiency involving reflux in the segment to be treated - CEAP-clinical classification = 2 - Physical condition allowing ambulation after the procedure. - Agree to comply with the Clinical investigation plan and follow-up schedule of the study - Targeted tissue reachable for treatment with the device. - Age over 22 years at the time of enrollment. - No acute venous thrombosis. - No complete or near complete deep vein post-thrombotic disease. - Patient has signed and understood the written informed consent. Exclusion Criteria: - Patient is pregnant - Known allergic reaction to anesthetics to be used. - Legally incapacitated or imprisoned patients - Patient's vein target not clearly visible on the ultrasound images (in B mode) at the inclusion visit - Patient participating in another clinical trial involving an investigational drug or device. - Ankle-brachial index <7 (ABI) - Undergoing active anticoagulant therapy within the last 6 months - Diameter of the treated anatomical segment below = 2mm & above > 20mm - Patients where HIFU cannot be delivered to tissues where macro calcifications induce a significant shadow in the ultrasonic image - Patients where EPack must be put in contact with an ulcer - Patients with significant thick scars on the skin over the segment to be treated - Security distance respected in regards of : - nerves & bones - the surrounding vessels - Patient who may not be considered as good candidates for treatment by the investigator outside the explicit exclusion criteria above listed

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Sonovein Treatment
The Sonovein System provides High Intensity Focused Ultrasound (HIFU) ablation of soft tissue. The energy is delivered via an extra-corporeal treatment probe, which includes an imaging system. The high-energy ultrasound waves propagate through the skin and are focused on a portion of the target tissue, generating intense heat and causing local cell apoptosis and progressive tissue volume reduction over the following months in the tissue. The process is then repeated in a stepwise fashion.

Locations

Country Name City State
Austria Praxis für Phlebologie Melk
Czechia Phlebomedica s.r.o Rícany
United States Englewood Health Englewood New Jersey
United States Northwell Health Lake Success New York

Sponsors (1)

Lead Sponsor Collaborator
Theraclion

Countries where clinical trial is conducted

United States,  Austria,  Czechia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Vein Occlusion Rate Percentage of limbs with occlusion of the treated vein (as measured by Duplex ultrasound) 12 months
Secondary Complications Number of limbs presenting complications and side effects resulting from the GSV intervention 12 months
Secondary Reflux-free Rate Percentage of limbs without reflux in the treated vein (as measured by Duplex ultrasound) 12 months
Secondary Venous Clinical Severity Score (VCSS) Assessment of venous disease (Scale 0-30: MIN=0 (least severe); MAX=30 (most severe)) 12 months
Secondary Clinical-Etiology-Anatomy-Pathophysiology (CEAP) Clinical signs and symptoms of lower limb venous disease (Scale C0-C6: MIN: C0=no visible or palpable signs of venous disease; MAX: C6=active venous ulcer) 12 months
See also
  Status Clinical Trial Phase
Terminated NCT02462096 - A Feasibility Study of the ReLeaf Catheter System N/A
Enrolling by invitation NCT05504070 - Venclose digiRF System Post Market Study N/A
Completed NCT05507346 - A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity Lymphedema N/A
Recruiting NCT05622500 - Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease N/A
Completed NCT03283800 - Copper Impact on Venous Insufficiency and Lipodermatosclerosis N/A
Completed NCT02236338 - Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein Phase 4
Terminated NCT02248740 - Radiofrequency Ablation vs. Laser Ablation of the Incompetent Small Saphenous Vein Phase 4
Completed NCT01501188 - Efficacy Study of Kinesio Taping to Treat Muscular and Joint Problems in Chronic Venous Insufficiency Phase 1
Recruiting NCT05982405 - Long-term Effects of Inspiratory Muscle Training in Chronic Venous Insufficiency N/A
Completed NCT05383469 - Efficacy of Active Versus Passive Methods in Chronic Venous Insufficiency N/A
Completed NCT06238791 - Plantar Pressure Analysis and Foot Biomechanics in Lipedema and Chronic Venous Disease
Withdrawn NCT02559427 - SPA Therapy in the Treatment of Sleep Apnea Syndrome N/A
Completed NCT02346058 - Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins Phase 4
Withdrawn NCT05047302 - Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System-Canada N/A
Active, not recruiting NCT04339075 - Registry to Investigate the Efficacy and Safety of VenaBlock VeIn SEaling System for VaRicose Veins in SingApore
Active, not recruiting NCT04580160 - Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System N/A
Not yet recruiting NCT02927483 - Study to Assess the Efficacy and Safety of Endolex Forte VErsus Diosmin and Hesperidin in Reducing VeNous Insufficiency Phase 3
Completed NCT02015221 - Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort N/A
Completed NCT02050061 - Chronic Venous Insufficiency; Impact of Compression Stockings on Quality of Life N/A
Completed NCT01432795 - Practicability of Gliding Aids for Medical Compression Stockings Phase 4